How GLP-1 Medications Actually Work

The mechanism behind semaglutide and tirzepatide, explained step by step — gut hormones, brain signaling, slowed digestion, and why the weight comes off without constant hunger.

The hormone your gut already makes Every time you eat, specialized cells in your intestine release glucagon-like peptide-1 (GLP-1) — one of several “incretin” hormones that tell the rest of your body food has arrived. Natural GLP-1 does four important things: 1. Signals fullness to the brain. GLP-1 receptors in the hypothalamus and brainstem dial down appetite and — many patients report — quiet the constant background chatter about food (“food noise”). 2. Slows stomach emptying. Food stays in your stomach longer, stretching fullness across hours instead of minutes. 3. Boosts insulin when glucose is high. GLP-1 amplifies insulin release only when blood sugar is elevated, which is why these drugs rarely cause hypoglycemia on their own. 4. Suppresses glucagon. Less stored sugar gets dumped into the bloodstream after meals. The catch: natural GLP-1 survives roughly two minutes before the enzyme DPP-4 destroys it. You cannot feel meaningfully fuller from a hormone that disappears that fast. ## What the medications change Semaglutide, tirzepatide, and liraglutide are engineered analogs — molecules shaped like GLP-1 but modified to dodge breakdown and to ride along on the blood protein albumin. The result is a hormone signal that lasts a week (semaglutide, tirzepatide) instead of two minutes. Pharmacologic levels are also far higher than natural post-meal levels, which is why the appetite effect is so much stronger than what any meal produces. Tirzepatide goes one step further: it also activates the GIP receptor, a second incretin pathway. The dual signal appears to produce more weight loss than GLP-1 alone (SURMOUNT-1’s 20.9% vs. STEP 1’s 14.9%, and ≈20% vs ≈14% head-to-head in SURMOUNT-5), possibly by improving how fat tissue handles energy and by reinforcing the brain’s satiety signaling. Retatrutide, still in trials, adds a third receptor — glucagon — which increases energy expenditure. ## Why the weight actually comes off People on GLP-1s eat substantially less — typically a 20–35% reduction in calorie intake in feeding studies — without feeling like they are fighting themselves. The drugs do not “melt fat” or meaningfully speed metabolism (except via the glucagon mechanism in investigational triple agonists). They make a calorie deficit achievable by changing the inputs to hunger: - Meals satisfy sooner, so portions shrink. - Hunger between meals fades, so snacking and grazing drop. - For many, reward-driven eating (stress eating, cravings) quiets noticeably — there is active research on GLP-1 receptors in the brain’s reward circuitry, including effects on alcohol intake. ## Why side effects happen The same mechanisms that drive weight loss explain most side effects. Slowed stomach emptying causes nausea, reflux, and the “food sits like a brick” feeling — worst right after dose increases, before the gut adapts. Less food and slower transit cause constipation. This is also why dose titration is gradual: the gut needs weeks to adapt at each step. The practical playbook is in managing side effects. ## Why the effect fades if you stop GLP-1 analogs do not rewire your set point permanently — they substitute a strong satiety signal for one your body was under-producing relative to its weight-defending biology. Stop the drug and the old signaling returns, usually with most of the appetite. The STEP 1 extension study found participants regained roughly two-thirds of lost weight within a year of stopping. That is not a moral failure; it is hormone biology — and it is why maintenance strategy (including lower-dose maintenance) matters as much as the loss phase.